Panama

Panama

Hepatitis B

Download HBV data

Prevalence of chronic HBV (HBsAg+)

National
Download
Value (%) Year Type Source
1.3 (0.97 - 1.74) 2015 Modelled WHO
1.68 (1.39 - 2.02) 2013 Modelled Schweitzer et al, 2015
0.54 (0.43 - 0.65) 2019 Modelled IHME, GBD 2019 (accessed 2020)
0.63 (0.51 - 0.73) 2018 Modelled IHME, GBD 2019 (accessed 2022)
0.64 (0.53 - 0.75) 2017 Modelled IHME, GBD 2019 (accessed 2022)
0.65 (0.54 - 0.76) 2016 Modelled IHME, GBD 2019 (accessed 2022)
0.66 (0.54 - 0.79) 2015 Modelled IHME, GBD 2019 (accessed 2022)
0.67 (0.54 - 0.80) 2014 Modelled IHME, GBD 2019 (accessed 2022)
0.69 (0.55 - 0.82) 2013 Modelled IHME, GBD 2019 (accessed 2022)
0.71 (0.56 - 0.84) 2012 Modelled IHME, GBD 2019 (accessed 2022)
0.72 (0.57 - 0.86) 2011 Modelled IHME, GBD 2019 (accessed 2022)
0.73 (0.57 - 0.88) 2010 Modelled IHME, GBD 2019 (accessed 2022)
0.74 (0.58 - 0.88) 2009 Modelled IHME, GBD 2019 (accessed 2022)
0.76 (0.60 - 0.90) 2008 Modelled IHME, GBD 2019 (accessed 2022)
0.78 (0.62 - 0.93) 2007 Modelled IHME, GBD 2019 (accessed 2022)
0.8 (0.64 - 0.95) 2006 Modelled IHME, GBD 2019 (accessed 2022)
0.8 (0.64 - 0.97) 2005 Modelled IHME, GBD 2019 (accessed 2022)
0.81 (0.65 - 0.97) 2004 Modelled IHME, GBD 2019 (accessed 2022)
0.82 (0.66 - 0.98) 2003 Modelled IHME, GBD 2019 (accessed 2022)
0.84 (0.68 - 1) 2002 Modelled IHME, GBD 2019 (accessed 2022)
0.85 (0.69 - 1.01) 2001 Modelled IHME, GBD 2019 (accessed 2022)
0.86 (0.69 - 1.02) 2000 Modelled IHME, GBD 2019 (accessed 2022)
0.86 (0.69 - 1.02) 1999 Modelled IHME, GBD 2019 (accessed 2022)
0.87 (0.71 - 1.04) 1998 Modelled IHME, GBD 2019 (accessed 2022)
0.89 (0.72 - 1.06) 1997 Modelled IHME, GBD 2019 (accessed 2022)
0.9 (0.72 - 1.08) 1996 Modelled IHME, GBD 2019 (accessed 2022)
0.91 (0.72 - 1.10) 1995 Modelled IHME, GBD 2019 (accessed 2022)
0.91 (0.73 - 1.09) 1994 Modelled IHME, GBD 2019 (accessed 2022)
0.91 (0.73 - 1.09) 1993 Modelled IHME, GBD 2019 (accessed 2022)
0.91 (0.73 - 1.08) 1992 Modelled IHME, GBD 2019 (accessed 2022)
0.91 (0.72 - 1.08) 1991 Modelled IHME, GBD 2019 (accessed 2022)
0.91 (0.72 - 1.09) 1990 Modelled IHME, GBD 2019 (accessed 2022)
0.59 (0.47 - 0.70) 2019 Modelled IHME, GBD 2019 (accessed 2022)
Showing out of
Show more
Children under-5 years
Download
Value (%) Year Type Source
0.22 (0.15 - 0.33) 2015 Modelled WHO
0.08 (0.05 - 0.11) 2019 Modelled IHME, GBD 2019 (accessed 2020)
0.11 (0.07 - 0.14) 2019 Modelled IHME, GBD 2019 (accessed 2022)
0.11 (0.07 - 0.14) 2018 Modelled IHME, GBD 2019 (accessed 2022)
0.11 (0.08 - 0.15) 2017 Modelled IHME, GBD 2019 (accessed 2022)
0.16 (0.11 - 0.21) 2016 Modelled IHME, GBD 2019 (accessed 2022)
0.2 (0.14 - 0.28) 2015 Modelled IHME, GBD 2019 (accessed 2022)
0.2 (0.13 - 0.27) 2014 Modelled IHME, GBD 2019 (accessed 2022)
0.18 (0.12 - 0.24) 2013 Modelled IHME, GBD 2019 (accessed 2022)
0.15 (0.11 - 0.21) 2012 Modelled IHME, GBD 2019 (accessed 2022)
0.13 (0.09 - 0.18) 2011 Modelled IHME, GBD 2019 (accessed 2022)
0.13 (0.09 - 0.17) 2010 Modelled IHME, GBD 2019 (accessed 2022)
0.13 (0.09 - 0.18) 2009 Modelled IHME, GBD 2019 (accessed 2022)
0.15 (0.10 - 0.20) 2008 Modelled IHME, GBD 2019 (accessed 2022)
0.17 (0.11 - 0.22) 2007 Modelled IHME, GBD 2019 (accessed 2022)
0.18 (0.12 - 0.24) 2006 Modelled IHME, GBD 2019 (accessed 2022)
0.19 (0.13 - 0.25) 2005 Modelled IHME, GBD 2019 (accessed 2022)
0.18 (0.12 - 0.24) 2004 Modelled IHME, GBD 2019 (accessed 2022)
0.17 (0.11 - 0.22) 2003 Modelled IHME, GBD 2019 (accessed 2022)
0.15 (0.11 - 0.20) 2002 Modelled IHME, GBD 2019 (accessed 2022)
0.14 (0.10 - 0.18) 2001 Modelled IHME, GBD 2019 (accessed 2022)
0.13 (0.09 - 0.17) 2000 Modelled IHME, GBD 2019 (accessed 2022)
0.18 (0.13 - 0.24) 1999 Modelled IHME, GBD 2019 (accessed 2022)
0.3 (0.22 - 0.40) 1998 Modelled IHME, GBD 2019 (accessed 2022)
0.44 (0.32 - 0.60) 1997 Modelled IHME, GBD 2019 (accessed 2022)
0.56 (0.41 - 0.77) 1996 Modelled IHME, GBD 2019 (accessed 2022)
0.61 (0.44 - 0.85) 1995 Modelled IHME, GBD 2019 (accessed 2022)
0.62 (0.45 - 0.84) 1994 Modelled IHME, GBD 2019 (accessed 2022)
0.62 (0.45 - 0.83) 1993 Modelled IHME, GBD 2019 (accessed 2022)
0.62 (0.44 - 0.82) 1992 Modelled IHME, GBD 2019 (accessed 2022)
0.61 (0.43 - 0.81) 1991 Modelled IHME, GBD 2019 (accessed 2022)
0.61 (0.42 - 0.81) 1990 Modelled IHME, GBD 2019 (accessed 2022)
0.07 (0.05 - 0.09) 2020 Modelled WHO
Showing out of
Show more
Technical notes

Number of people living with chronic HBV

National
Download
Value Year Type Source
22,602 (17,953 - 26,977) 2019 Modelled IHME, GBD 2019 (accessed 2020)
23,249 (18,560 - 27,636) 2019 Modelled IHME, GBD 2019 (accessed 2022)
24,248 (19,846 - 28,130) 2018 Modelled IHME, GBD 2019 (accessed 2022)
24,443 (20,079 - 28,427) 2017 Modelled IHME, GBD 2019 (accessed 2022)
24,174 (19,849 - 28,176) 2016 Modelled IHME, GBD 2019 (accessed 2022)
23,922 (19,385 - 28,579) 2015 Modelled IHME, GBD 2019 (accessed 2022)
23,756 (19,135 - 28,468) 2014 Modelled IHME, GBD 2019 (accessed 2022)
23,950 (19,160 - 28,620) 2013 Modelled IHME, GBD 2019 (accessed 2022)
24,213 (19,226 - 28,830) 2012 Modelled IHME, GBD 2019 (accessed 2022)
24,327 (19,208 - 28,939) 2011 Modelled IHME, GBD 2019 (accessed 2022)
24,117 (18,984 - 28,903) 2010 Modelled IHME, GBD 2019 (accessed 2022)
23,960 (18,876 - 28,465) 2009 Modelled IHME, GBD 2019 (accessed 2022)
24,151 (19,167 - 28,787) 2008 Modelled IHME, GBD 2019 (accessed 2022)
24,424 (19,455 - 29,167) 2007 Modelled IHME, GBD 2019 (accessed 2022)
24,541 (19,571 - 29,473) 2006 Modelled IHME, GBD 2019 (accessed 2022)
24,303 (19,517 - 29,257) 2005 Modelled IHME, GBD 2019 (accessed 2022)
24,024 (19,355 - 28,815) 2004 Modelled IHME, GBD 2019 (accessed 2022)
24,011 (19,339 - 28,567) 2003 Modelled IHME, GBD 2019 (accessed 2022)
24,071 (19,426 - 28,630) 2002 Modelled IHME, GBD 2019 (accessed 2022)
24,029 (19,368 - 28,392) 2001 Modelled IHME, GBD 2019 (accessed 2022)
23,741 (19,091 - 28,159) 2000 Modelled IHME, GBD 2019 (accessed 2022)
23,443 (18,910 - 27,887) 1999 Modelled IHME, GBD 2019 (accessed 2022)
23,361 (18,823 - 27,714) 1998 Modelled IHME, GBD 2019 (accessed 2022)
23,343 (18,874 - 27,723) 1997 Modelled IHME, GBD 2019 (accessed 2022)
23,252 (18,741 - 27,981) 1996 Modelled IHME, GBD 2019 (accessed 2022)
22,966 (18,379 - 27,763) 1995 Modelled IHME, GBD 2019 (accessed 2022)
22,551 (18,070 - 27,033) 1994 Modelled IHME, GBD 2019 (accessed 2022)
22,139 (17,751 - 26,421) 1993 Modelled IHME, GBD 2019 (accessed 2022)
21,722 (17,344 - 25,902) 1992 Modelled IHME, GBD 2019 (accessed 2022)
21,293 (16,908 - 25,376) 1991 Modelled IHME, GBD 2019 (accessed 2022)
20,847 (16,464 - 24,903) 1990 Modelled IHME, GBD 2019 (accessed 2022)
Showing out of
Show more

HBV-related death rate

National
Download
Value (per 100,000) Year Type Source
0.83 (0.58 - 1.15) 2019 Modelled IHME, GBD 2019 (accessed 2020)
0.96 (0.77 - 1.19) 1990 Modelled IHME, GBD 2019 (accessed 2022)
0.94 (0.76 - 1.18) 1991 Modelled IHME, GBD 2019 (accessed 2022)
0.95 (0.76 - 1.17) 1992 Modelled IHME, GBD 2019 (accessed 2022)
0.98 (0.80 - 1.21) 1993 Modelled IHME, GBD 2019 (accessed 2022)
0.95 (0.77 - 1.17) 1994 Modelled IHME, GBD 2019 (accessed 2022)
0.96 (0.78 - 1.20) 1995 Modelled IHME, GBD 2019 (accessed 2022)
0.95 (0.77 - 1.18) 1996 Modelled IHME, GBD 2019 (accessed 2022)
0.94 (0.76 - 1.17) 1997 Modelled IHME, GBD 2019 (accessed 2022)
0.87 (0.70 - 1.10) 1998 Modelled IHME, GBD 2019 (accessed 2022)
0.82 (0.65 - 1.03) 1999 Modelled IHME, GBD 2019 (accessed 2022)
0.78 (0.62 - 0.98) 2000 Modelled IHME, GBD 2019 (accessed 2022)
0.79 (0.62 - 1) 2001 Modelled IHME, GBD 2019 (accessed 2022)
0.81 (0.64 - 1.02) 2002 Modelled IHME, GBD 2019 (accessed 2022)
0.85 (0.67 - 1.07) 2003 Modelled IHME, GBD 2019 (accessed 2022)
0.88 (0.70 - 1.10) 2005 Modelled IHME, GBD 2019 (accessed 2022)
0.85 (0.68 - 1.07) 2004 Modelled IHME, GBD 2019 (accessed 2022)
0.89 (0.70 - 1.12) 2006 Modelled IHME, GBD 2019 (accessed 2022)
0.83 (0.66 - 1.04) 2007 Modelled IHME, GBD 2019 (accessed 2022)
0.81 (0.65 - 1) 2008 Modelled IHME, GBD 2019 (accessed 2022)
0.75 (0.60 - 0.94) 2010 Modelled IHME, GBD 2019 (accessed 2022)
0.77 (0.62 - 0.97) 2009 Modelled IHME, GBD 2019 (accessed 2022)
0.77 (0.61 - 0.97) 2011 Modelled IHME, GBD 2019 (accessed 2022)
0.79 (0.63 - 1) 2012 Modelled IHME, GBD 2019 (accessed 2022)
0.8 (0.63 - 1) 2013 Modelled IHME, GBD 2019 (accessed 2022)
0.82 (0.64 - 1.03) 2014 Modelled IHME, GBD 2019 (accessed 2022)
0.82 (0.65 - 1.05) 2016 Modelled IHME, GBD 2019 (accessed 2022)
0.83 (0.63 - 1.09) 2017 Modelled IHME, GBD 2019 (accessed 2022)
0.82 (0.64 - 1.04) 2015 Modelled IHME, GBD 2019 (accessed 2022)
0.83 (0.59 - 1.14) 2018 Modelled IHME, GBD 2019 (accessed 2022)
0.82 (0.58 - 1.15) 2019 Modelled IHME, GBD 2019 (accessed 2022)
Showing out of
Show more
Technical notes

HBV-related deaths

National
Download
Value Year Type Source
123 2016 Modelled WHO
23 (18 - 29) 1990 Modelled IHME, GBD 2019 (accessed 2022)
23 (19 - 29) 1991 Modelled IHME, GBD 2019 (accessed 2022)
25 (20 - 31) 1993 Modelled IHME, GBD 2019 (accessed 2022)
24 (19 - 29) 1992 Modelled IHME, GBD 2019 (accessed 2022)
25 (20 - 30) 1994 Modelled IHME, GBD 2019 (accessed 2022)
26 (21 - 32) 1996 Modelled IHME, GBD 2019 (accessed 2022)
26 (21 - 32) 1995 Modelled IHME, GBD 2019 (accessed 2022)
24 (20 - 31) 1998 Modelled IHME, GBD 2019 (accessed 2022)
26 (21 - 32) 1997 Modelled IHME, GBD 2019 (accessed 2022)
23 (19 - 29) 1999 Modelled IHME, GBD 2019 (accessed 2022)
23 (18 - 29) 2000 Modelled IHME, GBD 2019 (accessed 2022)
24 (19 - 31) 2002 Modelled IHME, GBD 2019 (accessed 2022)
24 (19 - 30) 2001 Modelled IHME, GBD 2019 (accessed 2022)
26 (21 - 33) 2003 Modelled IHME, GBD 2019 (accessed 2022)
27 (21 - 33) 2004 Modelled IHME, GBD 2019 (accessed 2022)
28 (22 - 35) 2005 Modelled IHME, GBD 2019 (accessed 2022)
29 (23 - 36) 2006 Modelled IHME, GBD 2019 (accessed 2022)
28 (22 - 34) 2007 Modelled IHME, GBD 2019 (accessed 2022)
27 (22 - 34) 2008 Modelled IHME, GBD 2019 (accessed 2022)
26 (21 - 33) 2009 Modelled IHME, GBD 2019 (accessed 2022)
26 (21 - 33) 2010 Modelled IHME, GBD 2019 (accessed 2022)
27 (22 - 34) 2011 Modelled IHME, GBD 2019 (accessed 2022)
29 (23 - 36) 2012 Modelled IHME, GBD 2019 (accessed 2022)
29 (23 - 37) 2013 Modelled IHME, GBD 2019 (accessed 2022)
32 (25 - 41) 2016 Modelled IHME, GBD 2019 (accessed 2022)
31 (24 - 39) 2014 Modelled IHME, GBD 2019 (accessed 2022)
31 (25 - 40) 2015 Modelled IHME, GBD 2019 (accessed 2022)
33 (25 - 44) 2017 Modelled IHME, GBD 2019 (accessed 2022)
34 (24 - 47) 2018 Modelled IHME, GBD 2019 (accessed 2022)
34 (24 - 48) 2019 Modelled IHME, GBD 2019 (accessed 2022)
34 (24 - 48) 2019 Modelled IHME, GBD 2019 (accessed 2020)
Showing out of
Show more
Technical notes

Percent of liver cancer deaths attributable to HBV

National
Download
Value (%) Year Type Source
10 (7 - 13) 1990 Modelled IHME, GBD 2019 (accessed 2022)
9 (7 - 13) 1991 Modelled IHME, GBD 2019 (accessed 2022)
9 (7 - 12) 1992 Modelled IHME, GBD 2019 (accessed 2022)
9 (7 - 12) 1993 Modelled IHME, GBD 2019 (accessed 2022)
9 (7 - 12) 1994 Modelled IHME, GBD 2019 (accessed 2022)
9 (7 - 12) 1995 Modelled IHME, GBD 2019 (accessed 2022)
9 (6 - 12) 1996 Modelled IHME, GBD 2019 (accessed 2022)
8 (6 - 10) 1998 Modelled IHME, GBD 2019 (accessed 2022)
8 (6 - 11) 1997 Modelled IHME, GBD 2019 (accessed 2022)
7 (5 - 10) 1999 Modelled IHME, GBD 2019 (accessed 2022)
7 (5 - 10) 2000 Modelled IHME, GBD 2019 (accessed 2022)
7 (5 - 10) 2002 Modelled IHME, GBD 2019 (accessed 2022)
7 (5 - 10) 2001 Modelled IHME, GBD 2019 (accessed 2022)
7 (6 - 10) 2003 Modelled IHME, GBD 2019 (accessed 2022)
8 (6 - 10) 2004 Modelled IHME, GBD 2019 (accessed 2022)
8 (6 - 11) 2006 Modelled IHME, GBD 2019 (accessed 2022)
8 (6 - 11) 2005 Modelled IHME, GBD 2019 (accessed 2022)
8 (6 - 11) 2007 Modelled IHME, GBD 2019 (accessed 2022)
8 (6 - 11) 2008 Modelled IHME, GBD 2019 (accessed 2022)
9 (6 - 12) 2009 Modelled IHME, GBD 2019 (accessed 2022)
9 (6 - 12) 2011 Modelled IHME, GBD 2019 (accessed 2022)
8 (6 - 11) 2010 Modelled IHME, GBD 2019 (accessed 2022)
8 (6 - 12) 2012 Modelled IHME, GBD 2019 (accessed 2022)
8 (6 - 11) 2013 Modelled IHME, GBD 2019 (accessed 2022)
9 (6 - 12) 2014 Modelled IHME, GBD 2019 (accessed 2022)
9 (6 - 12) 2015 Modelled IHME, GBD 2019 (accessed 2022)
9 (6 - 13) 2017 Modelled IHME, GBD 2019 (accessed 2022)
9 (6 - 12) 2016 Modelled IHME, GBD 2019 (accessed 2022)
9 (6 - 13) 2018 Modelled IHME, GBD 2019 (accessed 2022)
9 (6 - 13) 2019 Modelled IHME, GBD 2019 (accessed 2022)
14 (10 - 20) 2019 Modelled IHME, GBD 2019 (accessed 2020)
Showing out of
Show more
Technical notes

Coverage of HepB birth dose

Newborns
Download
Value (%) Year Type Source
85 2019 Survey/reported WHO/UNICEF
85 2018 Survey/reported WHO/UNICEF
87 2017 Survey/reported WHO/UNICEF
84 2016 Survey/reported WHO/UNICEF
85 2015 Survey/reported WHO/UNICEF
84 2014 Survey/reported WHO/UNICEF
79 2013 Survey/reported WHO/UNICEF
87 2012 Survey/reported WHO/UNICEF
93 2011 Survey/reported WHO/UNICEF
89 2010 Survey/reported WHO/UNICEF
78 2009 Survey/reported WHO/UNICEF
80 2008 Survey/reported WHO/UNICEF
83 2007 Survey/reported WHO/UNICEF
79 2006 Survey/reported WHO/UNICEF
75 2005 Survey/reported WHO/UNICEF
85 2004 Survey/reported WHO/UNICEF
57 2003 Survey/reported WHO/UNICEF
30 2002 Survey/reported WHO/UNICEF
2 2001 Survey/reported WHO/UNICEF
86 2020 Survey/reported WHO/UNICEF
86 2021 Survey/reported WHO/UNICEF
Showing out of
Show more
Technical notes

Coverage of 3-dose hepatitis B vaccine

Infants
Download
Value (%) Year Type Source
88 2019 Survey/reported WHO/UNICEF
74 2020 Survey/reported WHO/UNICEF
74 2021 Survey/reported WHO/UNICEF
Showing out of
Show more
Technical notes

Number of needles/syringes per PWID per year

People who inject drugs (PWID)
Download
Value Year Type Source
0 (0 - 0) 2016 Survey/reported Harm Reduction International, 2016
Technical notes

Percent of PWID accessing OST

People who inject drugs (PWID)
Download
Value (%) Year Type Source
0 2016 Survey/reported Harm Reduction International, 2016
HBV National Action Plan
HBV elimination goal
HepB birth dose policy
Yes
Source: WHO
Year of birth dose introduction
2003
Source: WHO
Eligible for HBV generic medicines
Source: MPP
HCV National Action Plan
HCV elimination goal
At least one needle-syringe exchange program (NSP) operational
No
Source: Harm Reduction International
At least one opioid substitution therapy (OST) program operational
No
Source: Harm Reduction International
NSP in at least one prison
No
Source: Harm Reduction International
OST in at least one prison
No
Source: Harm Reduction International
% of substance use disorder facilities offering hepatitis testing
Many (31-60%)
Source: WHO
% of substance use disorder facilities offering hepatitis treatment
Most (61-100%)
Source: WHO

Hepatitis C

Download HCV data

Prevalence of chronic HCV (RNA+/cAg)

National
Download
Value (%) Year Type Source
0.3 (0.20 - 0.30) 2015 Modelled Blach et al, 2017
1.72 (1.39 - 2.11) 2019 Modelled IHME, GBD 2019 (accessed 2022)
1.71 (1.38 - 2.10) 2018 Modelled IHME, GBD 2019 (accessed 2022)
1.7 (1.38 - 2.09) 2017 Modelled IHME, GBD 2019 (accessed 2022)
1.7 (1.38 - 2.08) 2016 Modelled IHME, GBD 2019 (accessed 2022)
1.7 (1.36 - 2.08) 2015 Modelled IHME, GBD 2019 (accessed 2022)
1.7 (1.37 - 2.07) 2014 Modelled IHME, GBD 2019 (accessed 2022)
1.7 (1.37 - 2.08) 2013 Modelled IHME, GBD 2019 (accessed 2022)
1.7 (1.38 - 2.09) 2012 Modelled IHME, GBD 2019 (accessed 2022)
1.7 (1.37 - 2.10) 2011 Modelled IHME, GBD 2019 (accessed 2022)
1.7 (1.36 - 2.10) 2010 Modelled IHME, GBD 2019 (accessed 2022)
1.7 (1.36 - 2.08) 2009 Modelled IHME, GBD 2019 (accessed 2022)
1.69 (1.37 - 2.07) 2008 Modelled IHME, GBD 2019 (accessed 2022)
1.68 (1.36 - 2.06) 2007 Modelled IHME, GBD 2019 (accessed 2022)
1.67 (1.36 - 2.06) 2006 Modelled IHME, GBD 2019 (accessed 2022)
1.67 (1.35 - 2.05) 2005 Modelled IHME, GBD 2019 (accessed 2022)
1.66 (1.35 - 2.02) 2004 Modelled IHME, GBD 2019 (accessed 2022)
1.65 (1.34 - 2) 2003 Modelled IHME, GBD 2019 (accessed 2022)
1.64 (1.34 - 2) 2002 Modelled IHME, GBD 2019 (accessed 2022)
1.63 (1.32 - 1.99) 2001 Modelled IHME, GBD 2019 (accessed 2022)
1.63 (1.31 - 2) 2000 Modelled IHME, GBD 2019 (accessed 2022)
1.63 (1.32 - 1.98) 1999 Modelled IHME, GBD 2019 (accessed 2022)
1.64 (1.32 - 1.99) 1998 Modelled IHME, GBD 2019 (accessed 2022)
1.65 (1.33 - 2.01) 1997 Modelled IHME, GBD 2019 (accessed 2022)
1.66 (1.34 - 2.03) 1996 Modelled IHME, GBD 2019 (accessed 2022)
1.67 (1.34 - 2.05) 1995 Modelled IHME, GBD 2019 (accessed 2022)
1.68 (1.35 - 2.07) 1994 Modelled IHME, GBD 2019 (accessed 2022)
1.68 (1.36 - 2.08) 1993 Modelled IHME, GBD 2019 (accessed 2022)
1.69 (1.36 - 2.08) 1992 Modelled IHME, GBD 2019 (accessed 2022)
1.69 (1.36 - 2.09) 1991 Modelled IHME, GBD 2019 (accessed 2022)
1.7 (1.36 - 2.11) 1990 Modelled IHME, GBD 2019 (accessed 2022)
1.61 (1.30 - 1.98) 2019 Modelled IHME, GBD 2019 (accessed 2020)
Showing out of
Show more
Women of childbearing age (15–49 years)
Download
Value (%) Year Type Source
0.33 (0.20 - 0.36) 2019 Modelled Dugan et al., 2021
Technical notes

Number of people living with chronic HCV (RNA+/cAg)

National
Download
Value Year Type Source
12,000 (7,000 - 14,000) 2015 Modelled Blach et al, 2017
38,903 (31,098 - 48,192) 1990 Modelled IHME, GBD 2019 (accessed 2022)
39,666 (31,921 - 48,992) 1991 Modelled IHME, GBD 2019 (accessed 2022)
40,390 (32,495 - 49,688) 1992 Modelled IHME, GBD 2019 (accessed 2022)
41,076 (33,047 - 50,564) 1993 Modelled IHME, GBD 2019 (accessed 2022)
41,742 (33,421 - 51,247) 1994 Modelled IHME, GBD 2019 (accessed 2022)
42,405 (33,854 - 51,937) 1995 Modelled IHME, GBD 2019 (accessed 2022)
42,963 (34,462 - 52,363) 1996 Modelled IHME, GBD 2019 (accessed 2022)
43,385 (34,932 - 52,887) 1997 Modelled IHME, GBD 2019 (accessed 2022)
43,783 (35,225 - 53,219) 1998 Modelled IHME, GBD 2019 (accessed 2022)
44,295 (35,940 - 53,864) 1999 Modelled IHME, GBD 2019 (accessed 2022)
45,072 (36,350 - 55,216) 2000 Modelled IHME, GBD 2019 (accessed 2022)
46,059 (37,361 - 56,102) 2001 Modelled IHME, GBD 2019 (accessed 2022)
47,100 (38,269 - 57,267) 2002 Modelled IHME, GBD 2019 (accessed 2022)
48,179 (39,388 - 58,734) 2003 Modelled IHME, GBD 2019 (accessed 2022)
49,287 (40,249 - 60,264) 2004 Modelled IHME, GBD 2019 (accessed 2022)
50,418 (41,052 - 61,985) 2005 Modelled IHME, GBD 2019 (accessed 2022)
51,567 (42,026 - 63,337) 2006 Modelled IHME, GBD 2019 (accessed 2022)
52,752 (42,901 - 64,730) 2007 Modelled IHME, GBD 2019 (accessed 2022)
53,955 (43,704 - 66,242) 2008 Modelled IHME, GBD 2019 (accessed 2022)
55,154 (44,398 - 67,795) 2009 Modelled IHME, GBD 2019 (accessed 2022)
56,334 (45,084 - 69,461) 2010 Modelled IHME, GBD 2019 (accessed 2022)
57,412 (46,056 - 70,639) 2011 Modelled IHME, GBD 2019 (accessed 2022)
58,371 (47,258 - 71,320) 2012 Modelled IHME, GBD 2019 (accessed 2022)
59,274 (47,749 - 72,697) 2013 Modelled IHME, GBD 2019 (accessed 2022)
60,207 (48,608 - 73,487) 2014 Modelled IHME, GBD 2019 (accessed 2022)
61,367 (49,359 - 75,064) 2015 Modelled IHME, GBD 2019 (accessed 2022)
62,924 (51,009 - 76,635) 2016 Modelled IHME, GBD 2019 (accessed 2022)
64,606 (52,506 - 79,215) 2017 Modelled IHME, GBD 2019 (accessed 2022)
66,028 (53,577 - 80,798) 2018 Modelled IHME, GBD 2019 (accessed 2022)
66,895 (54,104 - 82,378) 2019 Modelled IHME, GBD 2019 (accessed 2020)
67,290 (54,479 - 82,828) 2019 Modelled IHME, GBD 2019 (accessed 2022)
Showing out of
Show more
Women of childbearing age (15–49 years)
Download
Value Year Type Source
3,600 (2,100 - 3,900) 2019 Modelled Dugan et al., 2021

HCV-related death rate

National
Download
Value (Deaths per 100,000) Year Type Source
3.94 (2.78 - 5.45) 2019 Modelled IHME, GBD 2019 (accessed 2020)
2.95 (2.39 - 3.62) 1990 Modelled IHME, GBD 2019 (accessed 2022)
2.89 (2.34 - 3.54) 1991 Modelled IHME, GBD 2019 (accessed 2022)
2.93 (2.39 - 3.60) 1992 Modelled IHME, GBD 2019 (accessed 2022)
3.04 (2.46 - 3.73) 1993 Modelled IHME, GBD 2019 (accessed 2022)
2.95 (2.39 - 3.64) 1994 Modelled IHME, GBD 2019 (accessed 2022)
3 (2.44 - 3.69) 1995 Modelled IHME, GBD 2019 (accessed 2022)
2.93 (2.39 - 3.59) 1996 Modelled IHME, GBD 2019 (accessed 2022)
3 (2.43 - 3.70) 1997 Modelled IHME, GBD 2019 (accessed 2022)
2.93 (2.39 - 3.63) 1998 Modelled IHME, GBD 2019 (accessed 2022)
2.8 (2.27 - 3.47) 1999 Modelled IHME, GBD 2019 (accessed 2022)
2.71 (2.20 - 3.36) 2000 Modelled IHME, GBD 2019 (accessed 2022)
2.85 (2.30 - 3.54) 2002 Modelled IHME, GBD 2019 (accessed 2022)
2.77 (2.23 - 3.46) 2001 Modelled IHME, GBD 2019 (accessed 2022)
3 (2.42 - 3.74) 2003 Modelled IHME, GBD 2019 (accessed 2022)
3.03 (2.44 - 3.77) 2004 Modelled IHME, GBD 2019 (accessed 2022)
3.12 (2.51 - 3.88) 2005 Modelled IHME, GBD 2019 (accessed 2022)
3.23 (2.62 - 3.98) 2006 Modelled IHME, GBD 2019 (accessed 2022)
3.24 (2.62 - 4) 2007 Modelled IHME, GBD 2019 (accessed 2022)
3.42 (2.78 - 4.22) 2008 Modelled IHME, GBD 2019 (accessed 2022)
3.55 (2.88 - 4.35) 2009 Modelled IHME, GBD 2019 (accessed 2022)
3.59 (2.91 - 4.42) 2010 Modelled IHME, GBD 2019 (accessed 2022)
3.69 (2.98 - 4.57) 2011 Modelled IHME, GBD 2019 (accessed 2022)
3.8 (3.06 - 4.69) 2012 Modelled IHME, GBD 2019 (accessed 2022)
3.81 (3.07 - 4.72) 2013 Modelled IHME, GBD 2019 (accessed 2022)
3.88 (3.13 - 4.79) 2014 Modelled IHME, GBD 2019 (accessed 2022)
3.89 (3.10 - 4.80) 2015 Modelled IHME, GBD 2019 (accessed 2022)
3.9 (3.15 - 4.84) 2016 Modelled IHME, GBD 2019 (accessed 2022)
3.91 (3.01 - 5.01) 2017 Modelled IHME, GBD 2019 (accessed 2022)
3.9 (2.89 - 5.20) 2018 Modelled IHME, GBD 2019 (accessed 2022)
3.94 (2.78 - 5.45) 2019 Modelled IHME, GBD 2019 (accessed 2022)
Showing out of
Show more
Technical notes

HCV-related deaths

National
Download
Value Year Type Source
131 2016 Modelled WHO
164 (116 - 227) 2019 Modelled IHME, GBD 2019 (accessed 2022)
164 (116 - 227) 2019 Modelled IHME, GBD 2019 (accessed 2020)
160 (118 - 213) 2018 Modelled IHME, GBD 2019 (accessed 2022)
157 (121 - 202) 2017 Modelled IHME, GBD 2019 (accessed 2022)
153 (124 - 190) 2016 Modelled IHME, GBD 2019 (accessed 2022)
149 (119 - 184) 2015 Modelled IHME, GBD 2019 (accessed 2022)
145 (117 - 180) 2014 Modelled IHME, GBD 2019 (accessed 2022)
140 (113 - 174) 2013 Modelled IHME, GBD 2019 (accessed 2022)
138 (111 - 170) 2012 Modelled IHME, GBD 2019 (accessed 2022)
131 (106 - 163) 2011 Modelled IHME, GBD 2019 (accessed 2022)
125 (102 - 154) 2010 Modelled IHME, GBD 2019 (accessed 2022)
122 (99 - 149) 2009 Modelled IHME, GBD 2019 (accessed 2022)
115 (94 - 142) 2008 Modelled IHME, GBD 2019 (accessed 2022)
107 (87 - 133) 2007 Modelled IHME, GBD 2019 (accessed 2022)
105 (85 - 129) 2006 Modelled IHME, GBD 2019 (accessed 2022)
99 (80 - 124) 2005 Modelled IHME, GBD 2019 (accessed 2022)
95 (77 - 118) 2004 Modelled IHME, GBD 2019 (accessed 2022)
92 (74 - 115) 2003 Modelled IHME, GBD 2019 (accessed 2022)
86 (70 - 107) 2002 Modelled IHME, GBD 2019 (accessed 2022)
82 (66 - 103) 2001 Modelled IHME, GBD 2019 (accessed 2022)
79 (64 - 98) 2000 Modelled IHME, GBD 2019 (accessed 2022)
80 (65 - 99) 1999 Modelled IHME, GBD 2019 (accessed 2022)
82 (67 - 102) 1998 Modelled IHME, GBD 2019 (accessed 2022)
82 (67 - 102) 1997 Modelled IHME, GBD 2019 (accessed 2022)
79 (65 - 97) 1996 Modelled IHME, GBD 2019 (accessed 2022)
79 (64 - 98) 1995 Modelled IHME, GBD 2019 (accessed 2022)
76 (62 - 94) 1994 Modelled IHME, GBD 2019 (accessed 2022)
77 (62 - 95) 1993 Modelled IHME, GBD 2019 (accessed 2022)
73 (59 - 90) 1992 Modelled IHME, GBD 2019 (accessed 2022)
71 (57 - 86) 1991 Modelled IHME, GBD 2019 (accessed 2022)
70 (57 - 86) 1990 Modelled IHME, GBD 2019 (accessed 2022)
Showing out of
Show more
Technical notes

Percent of liver cancer deaths attributable to HCV

National
Download
Value (%) Year Type Source
19 (15 - 24) 1990 Modelled IHME, GBD 2019 (accessed 2022)
19 (14 - 23) 1991 Modelled IHME, GBD 2019 (accessed 2022)
18 (14 - 23) 1992 Modelled IHME, GBD 2019 (accessed 2022)
18 (14 - 22) 1993 Modelled IHME, GBD 2019 (accessed 2022)
18 (13 - 22) 1994 Modelled IHME, GBD 2019 (accessed 2022)
18 (13 - 22) 1995 Modelled IHME, GBD 2019 (accessed 2022)
18 (14 - 23) 1996 Modelled IHME, GBD 2019 (accessed 2022)
18 (13 - 22) 1997 Modelled IHME, GBD 2019 (accessed 2022)
16 (12 - 21) 1999 Modelled IHME, GBD 2019 (accessed 2022)
17 (13 - 21) 1998 Modelled IHME, GBD 2019 (accessed 2022)
16 (12 - 20) 2000 Modelled IHME, GBD 2019 (accessed 2022)
16 (12 - 20) 2001 Modelled IHME, GBD 2019 (accessed 2022)
17 (13 - 21) 2004 Modelled IHME, GBD 2019 (accessed 2022)
16 (12 - 20) 2003 Modelled IHME, GBD 2019 (accessed 2022)
16 (12 - 20) 2002 Modelled IHME, GBD 2019 (accessed 2022)
17 (13 - 22) 2005 Modelled IHME, GBD 2019 (accessed 2022)
18 (14 - 22) 2006 Modelled IHME, GBD 2019 (accessed 2022)
19 (14 - 23) 2007 Modelled IHME, GBD 2019 (accessed 2022)
19 (15 - 24) 2008 Modelled IHME, GBD 2019 (accessed 2022)
21 (16 - 26) 2010 Modelled IHME, GBD 2019 (accessed 2022)
20 (16 - 25) 2009 Modelled IHME, GBD 2019 (accessed 2022)
21 (16 - 26) 2012 Modelled IHME, GBD 2019 (accessed 2022)
21 (16 - 27) 2011 Modelled IHME, GBD 2019 (accessed 2022)
21 (16 - 27) 2013 Modelled IHME, GBD 2019 (accessed 2022)
22 (16 - 28) 2014 Modelled IHME, GBD 2019 (accessed 2022)
23 (17 - 29) 2017 Modelled IHME, GBD 2019 (accessed 2022)
22 (17 - 29) 2015 Modelled IHME, GBD 2019 (accessed 2022)
23 (17 - 29) 2016 Modelled IHME, GBD 2019 (accessed 2022)
23 (17 - 30) 2018 Modelled IHME, GBD 2019 (accessed 2022)
24 (18 - 31) 2019 Modelled IHME, GBD 2019 (accessed 2022)
37 (28 - 46) 2019 Modelled IHME, GBD 2019 (accessed 2020)
Showing out of
Show more
Technical notes

Number of needles/syringes per PWID per year

People who inject drugs (PWID)
Download
Value Year Type Source
0 (0 - 0) 2016 Survey/reported Harm Reduction International, 2016
Technical notes

Percent of PWID accessing OST

People who inject drugs (PWID)
Download
Value (%) Year Type Source
0 2016 Survey/reported Harm Reduction International, 2016
HBV National Action Plan
HBV elimination goal
HepB birth dose policy
Yes
Source: WHO
Year of birth dose introduction
2003
Source: WHO
Eligible for HBV generic medicines
Source: MPP
HCV National Action Plan
HCV elimination goal
At least one needle-syringe exchange program (NSP) operational
No
Source: Harm Reduction International
At least one opioid substitution therapy (OST) program operational
No
Source: Harm Reduction International
NSP in at least one prison
No
Source: Harm Reduction International
OST in at least one prison
No
Source: Harm Reduction International
% of substance use disorder facilities offering hepatitis testing
Many (31-60%)
Source: WHO
% of substance use disorder facilities offering hepatitis treatment
Most (61-100%)
Source: WHO

Overview

HBV elimination goal
HCV elimination goal

Prevalence (national)

Modelled

HBV (HBsAg+)
0.59 (%)
2019
(0.47 - 0.7(%))
IHME, GBD 2019 (accessed 2022)
HCV (RNA/cAg+)
1.61 (%)
2019
(1.3 - 1.98(%))
IHME, GBD 2019 (accessed 2020)

Survey/surveillance

No data available
No data available

Hepatitis related deaths (national)

Modelled

HBV
34
2019
(24 - 48)
IHME, GBD 2019 (accessed 2022)

Survey/surveillance

No data available
HBV chart

Modelled

HCV
164
2019
(116 - 227)
IHME, GBD 2019 (accessed 2022)

Survey/surveillance

No data available
HCV chart

Prevalence < 5

HBV
0.07 (%)
2020, latest modelled
(0.05 - 0.09(%))
WHO

Prevalence PWID

No data available

Birth dose vaccination coverage (national)

Survey/surveillance

HBV
86 (%)
2021
WHO/UNICEF

No. of syringes/PWID/year

Survey/surveillance

HCV
0
2016
(0 - 0)
Harm Reduction International, 2016
Eligible for HBV generic medicines

Latest news

View all

News

Resources